Status:
COMPLETED
Changes in Muscle Strength, Inflammatory Markers, and Body Composition in Response to Alternate Day Fasting Combined With Krill Oil Supplementation in Adults With Overweight and Obesity
Lead Sponsor:
University of Glasgow
Conditions:
Obesity Associated Disorder
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
The goal of this double-blind, randomised, controlled trial is to determine the effects of LC n-3 PUFAs supplementation on changes in body composition and muscle strength during body weight loss and b...
Detailed Description
During the preparation phase, participants will be asked to take 4g/d krill oil capsules or placebo oil (mixed vegetable oil) with their healthy diet (their usual diet) for a period of 4 weeks. After ...
Eligibility Criteria
Inclusion
- Healthy (male/female)
- body mass index (BMI) of 25 - 39.9 kg/m2
- Aged between 25 and 65 years
- stable body weight for at least three months
Exclusion
- Smokers
- Food allergy
- On any dietary supplements or dietary regimes at the time of the study
- Participants with systolic/diastolic \<90/60 mmHg and \>140/90 mmHg
Key Trial Info
Start Date :
March 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06001632
Start Date
March 28 2022
End Date
October 1 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Glasgow, New Lister Building
Glasgow, Scotland, United Kingdom, G31 2ER